MODDHealthcare · Medical Devices

MODD Stock Forecast: Modular Medical, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026

$2.54

−3.79% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 11 of 100 as at 12 Sept 2026 — in the weakest quartile.

Market cap

$20.7M

Ticker Nerd rank

11 / 100

Median analyst target

—

Analysts covering

Revenue$0.0

Operating income−$6.5M

Net income−$6.5M

Free cash flow−$6.7M

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

−25.7%

+26.1%

YTD

−76.7%

−87.9%

From 52W high

−88.9%

From 52W low

+35.8%

$23

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

MODD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Modular Medical, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026

11 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Accruals

Issuance

Growth

Volatility

Revisions

Value

Quality

Momentum

Size (88): Smaller than most of the companies we track.

Momentum (1): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

MODD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MODD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says1 analysts

1 Buy0 Hold0 Sell

Recent analyst actionsNewest first

Date	Firm	Action	Rating	Target
21 Mar 2024	Benchmark	Reiterates	Speculative Buy	$5.00
21 Mar 2024	Benchmark	Reiterates	Speculative Buy	—
19 Sept 2023	Oppenheimer	Reiterates	Outperform	—
30 June 2023	Benchmark	Reiterates	Speculative Buy	—
19 May 2023	Oppenheimer	Maintains	Outperform	—
30 Jan 2023	Benchmark	Maintains	Speculative Buy	—
8 Apr 2022	Lake Street	Initiates	Buy	—
25 Mar 2022	Benchmark	Initiates	Speculative Buy	—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MODD appears on the weeks it earns a place.

Performance

MODD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Modular Medical, Inc. returned −87.9% against +17.5% for the S&P 500, dividends included.

MODD vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

MODD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Modular Medical, Inc. (MODD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −0.2×
Price / sales: —
Price / book: 1.3×
EV / EBITDA: −0.7×

Growth & margins

Revenue growth (YoY): —
Earnings growth (YoY): —
Gross margin: —
Operating margin: 0.0%
Net margin: 0.0%

Returns & dividend

Return on equity: −247.9%
Return on assets: −129.1%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Modular Medical, Inc. (MODD) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Modular Medical, Inc. has a market value of $20.7M and an enterprise value of $17.1M.
Revenue in the twelve months to 30 June 2026: $0.0.
Net income over the same four quarters: −$28.0M.
Free cash flow in the twelve months to 30 June 2026: −$28.0M.
Shares outstanding: 5.4M.
Trailing P/E: −0.2×; forward P/E: −4.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Modular Medical, Inc. employs 51 people.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Sept 2026

Data provided by Twelve Data

Peers

MODD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices

Company	Market cap	TKN rank
MODDModular Medical, Inc.	$20.7M	11
CTSOCytoSorbents Corp.	$20.2M	47
LFWDLifeward Ltd.	$20.0M	22
PLSMPulsenmore Ltd.	$16.4M	34
ARAYAccuray, Inc.	$29.7M	31
NMTCNeuroOne Medical Technologies Corp.	$14.2M	39
NSYSNortech Systems, Inc.	$31.2M	87

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Modular Medical, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest MODD news & analysis

Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026

Accesswire · 8 Sept 2026neutral

Modular Medical announced that CEO Jeb Besser will present and host one-on-one meetings at the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026, scheduled for September 15-16, 2026. The presentation is set for Tuesday, September 15 at 1:00 p.m.

Why it matters — A MODD watcher would care because this conference appearance gives the company's CEO a platform to present to and meet directly with investors ahead of the full commercial launch of its Pivot tubeless patch pump.

Modular Medical Secures National PBM Contract For Pivot Insulin Pump

Benzinga · 4 Sept 2026positive

Modular Medical Inc. announced it has signed a significant contract with a national U.S. pharmacy benefit manager (PBM) for its Pivot insulin pump. The agreement represents a notable commercial milestone for the company.

Why it matters — A national PBM contract could expand market access and reimbursement coverage for Modular Medical's Pivot insulin pump, strengthening the company's commercial position.

Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump

Accesswire · 4 Sept 2026positive

Modular Medical announced it has secured a contract with a national U.S. pharmacy benefit manager, making its Pivot tubeless insulin delivery system available through that PBM. The company is preparing for the commercial launch of its Pivot tubeless patch pump.

Why it matters — This contract expands distribution and potential patient access for Modular Medical's Pivot tubeless patch pump ahead of its commercial launch, a key commercial milestone for MODD watchers.

Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements

Accesswire · 3 Sept 2026positive

Modular Medical announced FDA clearance of software enhancements for its Pivot tubeless insulin patch pump system. The clearance covers upgrades including greater bolus-dosing flexibility, enhanced user-interface options, and other software improvements, and was received ahead of the company's planned fourth-quarter commercial launch.

Why it matters — This FDA clearance advances the Pivot system's readiness ahead of its planned full commercial launch, which is a key milestone for MODD watchers tracking the company's progress.

EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades

Benzinga · 3 Sept 2026positive

Modular Medical, Inc. announced that the U.S. Food & Drug Administration has cleared a set of software enhancements to its Pivot insulin delivery system. The FDA clearance was announced on Thursday.

Why it matters — FDA clearance of software upgrades to the Pivot system represents a regulatory milestone that could advance the product's development and market positioning.

FAQ

Frequently asked questions about MODD stock

Is MODD stock a buy right now?

Of the 1 analysts covering Modular Medical, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Modular Medical, Inc. 11 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MODD?

As at 12 Sept 2026, Modular Medical, Inc. ranks 11 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (88 of 100).

What is the MODD stock forecast for 2030?

No analyst covering Modular Medical, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MODD are extrapolating price history, which says nothing about the business.

How has MODD stock performed over the past year?

Modular Medical, Inc. returned -87.9% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Modular Medical, Inc. do?

Modular Medical, Inc. is a medical device company focused on developing insulin delivery technology for people living with diabetes.

What is the latest news on MODD?

The most recent item we track (Accesswire, 8 Sept 2026): "Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026". Modular Medical announced that CEO Jeb Besser will present and host one-on-one meetings at the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026, scheduled for September 15-16, 2026. The presentation is set for Tuesday, September 15 at 1:00 p.m.

Company

About Modular Medical, Inc.

Modular Medical, Inc. is a medical device company focused on developing insulin delivery technology for people living with diabetes. Its current product lineup centers on insulin pump systems, including the MODD1 two-part patch pump and the Pivot tubeless insulin delivery system, both designed to simplify daily insulin management. The company works within the diabetes care market, addressing the needs of people with type 1 diabetes and insulin-dependent type 2 diabetes. By emphasizing wearable, discreet, and easier-to-use pump formats, Modular Medical aims to make advanced insulin therapy more accessible and practical for a broader range of users. Headquartered in San Diego, California, Modular Medical positions its technology as an alternative to more complex traditional pump systems, with a focus on usability, convenience, and consistent delivery support in clinical and home-care settings.

51 employees · United States · https://www.modularmedical.com